NCT04633512View on ClinicalTrials.gov

Safety and Feasibility of ActivSightTM in Human

NAEnrolling by invitationINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Acute CholecystitisColorectal CancerDiverticulitis, ColonicObesity, MorbidInflammatory Bowel Diseases
Interventions
DEVICE

ActivSight

Use of ActivSight in patients undergoing laparoscopic or robot assisted intestinal anastomoses and patients undergoing laparoscopic or robot assisted cholecystectomy.

Trial Locations (3)

14203

Kaleida Health, University of Buffalo, Buffalo

77030

Memorial Hermann Texas Medical Center, Houston

77479

Memorial Hermann Sugar Land Hospital, Sugar Land

Sponsors

Lead Sponsor

Activ Surgical
All Listed Sponsors
collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

University at Buffalo

OTHER

collaborator

Ohio State University

OTHER

lead

Activ Surgical

INDUSTRY